Dynamic Regulation of the Cerebral Cavernous Malformation Pathway Controls Vascular Stability and Growth

Developmental Cell

Volumn 23, Issue 2, 2012, Pages 342-355

  Zheng, Xiangjian ^a   Xu, Chong ^a   Smith, Annie O ^c   Stratman, Amber N ^c   Zou, Zhiying ^a   Kleaveland, Benjamin ^d   Yuan, Lijun ^a,e   Didiku, Chuka ^a   Sen, Aslihan ^a   Liu, Xi ^a,e   Skuli, Nicolas ^a,b   Zaslavsky, Alexander ^b   Chen, Mei ^a   Cheng, Lan ^a   Davis, George E ^c   Kahn, Mark L ^a  

^a UNIVERSITY OF PENNSYLVANIA   (United States)

^b UNIVERSITY OF PENNSYLVANIA   (United States)

^c UNIVERSITY OF MISSOURI   (United States)

^d MASSACHUSETTS GENERAL HOSPITAL   (United States)

^e FOURTH MILITARY MEDICAL UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

CCM2L PROTEIN; ENDOCARDIAL GROWTH FACTOR; GROWTH FACTOR; MEMBRANE PROTEIN; UNCLASSIFIED DRUG;

ANGIOGENESIS; ANIMAL CELL CULTURE; ARTICLE; BLOOD VESSEL REACTIVITY; CANCER INHIBITION; CARDIOVASCULAR EFFECT; CAVERNOUS HEMANGIOMA; ENDOTHELIUM CELL; HUMAN; NONHUMAN; PHENOTYPE; PRIORITY JOURNAL; PROTEIN EXPRESSION; SIGNAL TRANSDUCTION; WOUND HEALING;

AMINO ACID SEQUENCE; ANIMALS; CENTRAL NERVOUS SYSTEM VASCULAR MALFORMATIONS; EMBRYO, MAMMALIAN; GENE EXPRESSION REGULATION, DEVELOPMENTAL; INTERCELLULAR JUNCTIONS; MICE; MICE, KNOCKOUT; MICROFILAMENT PROTEINS; MICROTUBULE-ASSOCIATED PROTEINS; MOLECULAR SEQUENCE DATA; NEOVASCULARIZATION, PATHOLOGIC; PROTEIN BINDING; PROTO-ONCOGENE PROTEINS; SEQUENCE ALIGNMENT; SEQUENCE HOMOLOGY, AMINO ACID; SIGNAL TRANSDUCTION;

EID: 84865085052     PISSN: 15345807     EISSN: 18781551     Source Type: Journal    
DOI: 10.1016/j.devcel.2012.06.004     Document Type: Article

References (33)

1. Borikova A.L., Dibble C.F., Sciaky N., Welch C.M., Abell A.N., Bencharit S., Johnson G.L. Rho kinase inhibition rescues the endothelial cell cerebral cavernous malformation phenotype. J. Biol. Chem. 2010, 285:11760-11764.
2. Boulday G., Blécon A., Petit N., Chareyre F., Garcia L.A., Niwa-Kawakita M., Giovannini M., Tournier-Lasserve E. Tissue-specific conditional CCM2 knockout mice establish the essential role of endothelial CCM2 in angiogenesis: implications for human cerebral cavernous malformations. Dis. Model. Mech. 2009, 2:168-177.
3. Clatterbuck R.E., Eberhart C.G., Crain B.J., Rigamonti D. Ultrastructural and immunocytochemical evidence that an incompetent blood-brain barrier is related to the pathophysiology of cavernous malformations. J. Neurol. Neurosurg. Psychiatry 2001, 71:188-192.
4. Conway E.M., Collen D., Carmeliet P. Molecular mechanisms of blood vessel growth. Cardiovasc. Res. 2001, 49:507-521.
5. Dejana E., Orsenigo F., Molendini C., Baluk P., McDonald D.M. Organization and signaling of endothelial cell-to-cell junctions in various regions of the blood and lymphatic vascular trees. Cell Tissue Res. 2009, 335:17-25.
6. Denier C., Goutagny S., Labauge P., Krivosic V., Arnoult M., Cousin A., Benabid A.L., Comoy J., Frerebeau P., Gilbert B., et al. Mutations within the MGC4607 gene cause cerebral cavernous malformations. Am. J. Hum. Genet. 2004, 74:326-337. Société Française de Neurochirurgie.
7. Gassmann M., Casagranda F., Orioli D., Simon H., Lai C., Klein R., Lemke G. Aberrant neural and cardiac development in mice lacking the ErbB4 neuregulin receptor. Nature 1995, 378:390-394.
8. Glading A., Han J., Stockton R.A., Ginsberg M.H. KRIT-1/CCM1 is a Rap1 effector that regulates endothelial cell cell junctions. J. Cell Biol. 2007, 179:247-254.
9. Iwamoto R., Yamazaki S., Asakura M., Takashima S., Hasuwa H., Miyado K., Adachi S., Kitakaze M., Hashimoto K., Raab G., et al. Heparin-binding EGF-like growth factor and ErbB signaling is essential for heart function. Proc. Natl. Acad. Sci. USA 2003, 100:3221-3226.
10. Jakobsson L., Franco C.A., Bentley K., Collins R.T., Ponsioen B., Aspalter I.M., Rosewell I., Busse M., Thurston G., Medvinsky A., et al. Endothelial cells dynamically compete for the tip cell position during angiogenic sprouting. Nat. Cell Biol. 2010, 12:943-953.
11. Kleaveland B., Zheng X., Liu J.J., Blum Y., Tung J.J., Zou Z., Sweeney S.M., Chen M., Guo L., Lu M.M., et al. Regulation of cardiovascular development and integrity by the heart of glass-cerebral cavernous malformation protein pathway. Nat. Med. 2009, 15:169-176.
12. Koh W., Stratman A.N., Sacharidou A., Davis G.E. In vitro three dimensional collagen matrix models of endothelial lumen formation during vasculogenesis and angiogenesis. Methods Enzymol. 2008, 443:83-101.
13. Lavine K.J., Yu K., White A.C., Zhang X., Smith C., Partanen J., Ornitz D.M. Endocardial and epicardial derived FGF signals regulate myocardial proliferation and differentiation in vivo. Dev. Cell 2005, 8:85-95.
14. Lee J.S., Yu Q., Shin J.T., Sebzda E., Bertozzi C., Chen M., Mericko P., Stadtfeld M., Zhou D., Cheng L., et al. Klf2 is an essential regulator of vascular hemodynamic forces in vivo. Dev. Cell 2006, 11:845-857.
15. Lu S.Y., Sheikh F., Sheppard P.C., Fresnoza A., Duckworth M.L., Detillieux K.A., Cattini P.A. FGF-16 is required for embryonic heart development. Biochem. Biophys. Res. Commun. 2008, 373:270-274.
16. Lu S.Y., Jin Y., Li X., Sheppard P., Bock M.E., Sheikh F., Duckworth M.L., Cattini P.A. Embryonic survival and severity of cardiac and craniofacial defects are affected by genetic background in fibroblast growth factor-16 null mice. DNA Cell Biol. 2010, 29:407-415.
17. Lyden D., Hattori K., Dias S., Costa C., Blaikie P., Butros L., Chadburn A., Heissig B., Marks W., Witte L., et al. Impaired recruitment of bone-marrow-derived endothelial and hematopoietic precursor cells blocks tumor angiogenesis and growth. Nat. Med. 2001, 7:1194-1201.
18. Mably J.D., Mohideen M.A., Burns C.G., Chen J.N., Fishman M.C. Heart of glass regulates the concentric growth of the heart in zebrafish. Curr. Biol. 2003, 13:2138-2147.
19. Mably J.D., Chuang L.P., Serluca F.C., Mohideen M.A., Chen J.N., Fishman M.C. santa and valentine pattern concentric growth of cardiac myocardium in the zebrafish. Development 2006, 133:3139-3146.
20. Murohara T., Horowitz J.R., Silver M., Tsurumi Y., Chen D., Sullivan A., Isner J.M. Vascular endothelial growth factor/vascular permeability factor enhances vascular permeability via nitric oxide and prostacyclin. Circulation 1998, 97:99-107.
21. Potente M., Gerhardt H., Carmeliet P. Basic and therapeutic aspects of angiogenesis. Cell 2011, 146:873-887.
22. Risau W. Mechanisms of angiogenesis. Nature 1997, 386:671-674.
23. Saint-Geniez M., D'Amore P.A. Development and pathology of the hyaloid, choroidal and retinal vasculature. Int. J. Dev. Biol. 2004, 48:1045-1058.
24. Senger D.R., Galli S.J., Dvorak A.M., Perruzzi C.A., Harvey V.S., Dvorak H.F. Tumor cells secrete a vascular permeability factor that promotes accumulation of ascites fluid. Science 1983, 219:983-985.
25. Stockton R.A., Shenkar R., Awad I.A., Ginsberg M.H. Cerebral cavernous malformations proteins inhibit Rho kinase to stabilize vascular integrity. J. Exp. Med. 2010, 207:881-896.
26. Stolt P.C., Jeon H., Song H.K., Herz J., Eck M.J., Blacklow S.C. Origins of peptide selectivity and phosphoinositide binding revealed by structures of disabled-1 PTB domain complexes. Structure 2003, 11:569-579.
27. Uhlik M.T., Temple B., Bencharit S., Kimple A.J., Siderovski D.P., Johnson G.L. Structural and evolutionary division of phosphotyrosine binding (PTB) domains. J. Mol. Biol. 2005, 345:1-20.
28. Voss K., Stahl S., Schleider E., Ullrich S., Nickel J., Mueller T.D., Felbor U. CCM3 interacts with CCM2 indicating common pathogenesis for cerebral cavernous malformations. Neurogenetics 2007, 8:249-256.
29. Voss K., Stahl S., Hogan B.M., Reinders J., Schleider E., Schulte-Merker S., Felbor U. Functional analyses of human and zebrafish 18-amino acid in-frame deletion pave the way for domain mapping of the cerebral cavernous malformation 3 protein. Hum. Mutat. 2009, 30:1003-1011.
30. Whitehead K.J., Plummer N.W., Adams J.A., Marchuk D.A., Li D.Y. Ccm1 is required for arterial morphogenesis: implications for the etiology of human cavernous malformations. Development 2004, 131:1437-1448.
31. Whitehead K.J., Chan A.C., Navankasattusas S., Koh W., London N.R., Ling J., Mayo A.H., Drakos S.G., Jones C.A., Zhu W., et al. The cerebral cavernous malformation signaling pathway promotes vascular integrity via Rho GTPases. Nat. Med. 2009, 15:177-184.
32. Zawistowski J.S., Stalheim L., Uhlik M.T., Abell A.N., Ancrile B.B., Johnson G.L., Marchuk D.A. CCM1 and CCM2 protein interactions in cell signaling: implications for cerebral cavernous malformations pathogenesis. Hum. Mol. Genet. 2005, 14:2521-2531.
33. Zheng X., Xu C., Di Lorenzo A., Kleaveland B., Zou Z., Seiler C., Chen M., Cheng L., Xiao J., He J., et al. CCM3 signaling through sterile 20-like kinases plays an essential role during zebrafish cardiovascular development and cerebral cavernous malformations. J. Clin. Invest. 2010, 120:2795-2804.